| scholarly article | Q13442814 |
| P2093 | author name string | Astrid-Solveig Schultz | |
| Florian Heyd | |||
| Marco Preussner | |||
| Ilka Wilhelmi | |||
| Monika Michel | |||
| P2860 | cites work | Tissue-specific alternative splicing remodels protein-protein interaction networks | Q48455031 |
| TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation. | Q50792035 | ||
| Getting under the skin of alternative splicing: identification of epithelial-specific splicing factors. | Q51747407 | ||
| The evolutionary landscape of alternative splicing in vertebrate species | Q56894874 | ||
| Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint | Q79765411 | ||
| Phosphorylation-Dependent Regulation of PSF by GSK3 Controls CD45 Alternative Splicing | Q24302148 | ||
| Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway | Q24324346 | ||
| Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers | Q24562579 | ||
| T cell activation | Q24658051 | ||
| Mechanisms of alternative pre-messenger RNA splicing | Q28131822 | ||
| A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
| OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3 | Q28513798 | ||
| ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle | Q28592239 | ||
| The two NF-kappaB activation pathways and their role in innate and adaptive immunity | Q29614355 | ||
| TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-kappaB activation | Q33876001 | ||
| The noncanonical NF-κB pathway | Q34031207 | ||
| An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming | Q34216981 | ||
| TNF receptor-associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling | Q34603380 | ||
| A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4. | Q34811491 | ||
| Noncanonical NF-kappaB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development | Q35149531 | ||
| PSF controls expression of histone variants and cellular viability in thymocytes | Q35534322 | ||
| Evolutionary dynamics of gene and isoform regulation in Mammalian tissues. | Q36598797 | ||
| Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn | Q36751866 | ||
| Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. | Q37178911 | ||
| Expanding TRAF function: TRAF3 as a tri-faced immune regulator | Q37887494 | ||
| Non-canonical NF-κB signaling activation and regulation: principles and perspectives | Q37948121 | ||
| Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). | Q38006770 | ||
| Alternative splicing networks regulated by signaling in human T cells. | Q39372815 | ||
| A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras. | Q39450030 | ||
| CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics | Q39527436 | ||
| An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition | Q39667327 | ||
| HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer | Q39763266 | ||
| Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation | Q40566781 | ||
| Tissue-specific splicing of disordered segments that embed binding motifs rewires protein interaction networks | Q41884066 | ||
| Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I | Q42015911 | ||
| Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells | Q42227779 | ||
| Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling | Q43142702 | ||
| Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. | Q44999948 | ||
| Regulation of naive T cell function by the NF-kappaB2 pathway | Q46071109 | ||
| Unique gene expression program of human germinal center T helper cells | Q47303246 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alternative mRNA splicing, via spliceosome | Q21114084 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 13651-13660 | |
| P577 | publication date | 2014-03-26 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells | |
| P478 | volume | 289 |
| Q93027444 | A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy |
| Q39056768 | Activation-Dependent TRAF3 Exon 8 Alternative Splicing Is Controlled by CELF2 and hnRNP C Binding to an Upstream Intronic Element |
| Q92501366 | Differential Interleukin-2 Transcription Kinetics Render Mouse but Not Human T Cells Vulnerable to Splicing Inhibition Early after Activation |
| Q92901441 | Metabonomic-Transcriptome Integration Analysis on Osteoarthritis and Rheumatoid Arthritis |
| Q52337490 | Negative Regulation of Interferon-β Production by Alternative Splicing of Tumor Necrosis Factor Receptor-Associated Factor 3 in Ducks. |
| Q40105947 | Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype |
| Q58580426 | Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses |
| Q27023925 | Roles of TRAF3 in T cells: many surprises |
| Q42365219 | Sec16 alternative splicing dynamically controls COPII transport efficiency |
| Q38801811 | TRAF3 as a powerful and multitalented regulator of lymphocyte functions. |
| Q35759267 | Targeting signaling factors for degradation, an emerging mechanism for TRAF functions |
Search more.